The abovementioned Maletziki et al. study reported that the level of IDO1 expression inversely affects cell sensitivity to indoximod, and higher expression of IDO1 in colorectal cancer cells than in breast cancer cells was previously observed [47,49]. The gene discussed is IDO1; the disease is breast carcinoma.